Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001972362-23-000786
Filing Date
2023-09-07
Accepted
2023-09-07 18:14:18
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3510
  Complete submission text file 0001972362-23-000786.txt   4928
Mailing Address 10955 VISTA SORRENTO PARKWAY SUITE 200 SAN DIEGO CA 92130
Business Address 10955 VISTA SORRENTO PARKWAY SUITE 200 SAN DIEGO CA 92130 (858) 751-4493
Janux Therapeutics, Inc. (Subject) CIK: 0001817713 (see all company filings)

EIN.: 822289112 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-40475 | Film No.: 231243286
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O JANUX THERAPEUTICS, INC. 11099 N. TORREY PINES ROAD, SUITE 290 LA JOLLA CA 92037
Business Address
Godfrey Wayne (Reporting) CIK: 0001866149 (see all company filings)

Type: 144